Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
R&D Collaborations
Filter     Order     Display # 
Date Item Title Hits
01 Sep 2010 Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP 4
30 Aug 2010 IntelGenx and RedHill Announce Definitive Agreement for Anti-Migraine Film Product 30
24 Aug 2010 Roche and Aileron Enter Multi-target Alliance to Develop Stapled Peptide Drugs for Diseases across Multiple Therapeutic Areas 8
17 Aug 2010 MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute 57
17 Aug 2010 Cryo-Cell Announces Celle(SM) Research and Development Collaboration With Department of Medicine, Monash University 59
17 Aug 2010 BAC and Octapharma Extend Collaboration for G-CSF Custom Ligand for Commercial Scale Manufacture 15
16 Aug 2010 International Society for Cellular Therapy (ISCT) joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership 12
12 Aug 2010 NextWave Pharmaceuticals and Tris Pharma Enter into CNS-focused Development and Commercialization Agreement 61
11 Aug 2010 Alectos Therapeutics Announces Collaboration With Merck to Develop Drugs for Alzheimer's Disease 101
11 Aug 2010 NeoStem and the Schepens Eye Research Institute to Study NeoStem's VSEL Technology in Retinal Diseases 68
11 Aug 2010 Crucell and Harvard (BIDMC) Join Forces with IAVI to Advance AdVac(R)-based AIDS Vaccine 23
06 Aug 2010 GenVec Announces New Agreement with Global Pharmaceutical Company 74
04 Aug 2010 GlaxoSmithKline and Amplimmune Form Global Strategic Collaboration 19
04 Aug 2010 TapImmune Signs Research and Technology License Option Agreement for Smallpox Vaccine 12
03 Aug 2010 Five Prime Therapeutics, Inc. Announces Strategic Alliance With GlaxoSmithKline to Discover Innovative Biologics for Skeletal Muscle Disorders 15
03 Aug 2010 Seattle Genetics Expands Antibody-Drug Conjugate Collaboration with Genentech 17
02 Aug 2010 Oxygen Biotherapeutics Signs CRADA With U.S. Navy to Study Treatment of Decompression Sickness Using Oxycyte(R) Emulsion 12
28 Jul 2010 Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH) 72
28 Jul 2010 Astellas to Pay $295 Million to Extend License of Regeneron's VelocImmune Antibody Technology through 2023 67
27 Jul 2010 Marina Biotech and University of Helsinki Expand Collaboration to Discover Novel Targeting Peptides With Marina's Proprietary Trp Cage Library 17
27 Jul 2010 Sinopharm and Merck Sign Statement of Mutual Intent 31
27 Jul 2010 SurModics and EGEN Announce Collaboration with Potential for Long-term Delivery of siRNA 77
27 Jul 2010 Envoy to Seek New Parkinson's Disease Therapy with Scripps 79
26 Jul 2010 Advanced Life Sciences Expands Antibiotic Pipeline 63
26 Jul 2010 Almirall signs a co-promotion agreement with Pfizer to commercialise Conbriza in Spain, a new therapeutic option to treat osteoporosis 23
16 Jul 2010 Galapagos NV (BE) - Galapagos and University of Bristol enter drug discovery collaboration in chronic pain 18
16 Jul 2010 A*STAR & CYTOS BIOTECHNOLOGY ESTABLISH INFLUENZA VACCINE COLLABORATION 19
14 Jul 2010 Cell Therapeutics, Inc. (CTI) Signs Long-Term Manufacturing Agreement for Pixantrone With NerPharMa 54
14 Jul 2010 Aestus Therapeutics Signs Agreement with Eisai to Develop Novel Treatments for Psychiatric Disorders 73
14 Jul 2010 Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration 22
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 30 of 829

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics